Age-Reversing Drugs and Devices in DermatologySACHS, D. L; VOORHEES, J. J.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 34-43, issn 0009-9236, 10 p.Article

Photoaged Skin:The Role of Neutrophils, Preventive Measures, and Potential Pharmacological TargetsRIJKEN, F; BRUIJNZEEL-KOOMEN, Cafm.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 120-124, issn 0009-9236, 5 p.Article

ZUR FRAGE ENDOKRINER NEBENWIRKUNGEN BEI DER MEDIKAMENTOESEN PROPHYLAXE CALCIUMHALTIGER HARNSTEINE = LA QUESTION DES EFFETS SECONDAIRES ENDOCRINIENS LORS DE LA PROPHYLAXIE MEDICAMENTEUSE DES CALCULS URINAIRES CONTENANT DU CALCIUMZIEGLER R; UHL K; MINNE H et al.1980; UROLOGE, A; DEU; DA. 1980; VOL. 19; NO 4; PP. 226-230; ABS. ENG; BIBL. 14 REF.Article

Effect of NFE2L2 Genetic Polymorphism on the Association Between Oral Estrogen Therapy and the Risk of Venous Thromboembolism in Postmenopausal WomenBOULIGAND, J; CABARET, O; CANONICO, M et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 60-64, issn 0009-9236, 5 p.Article

Are Circulating Metabolites Important in Drug-Drug Interactions?: Quantitative Analysis of Risk Prediction and Inhibitory PotencyYEUNG, C. K; FUJIOKA, Y; HACHAD, H et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 105-113, issn 0009-9236, 9 p.Article

Optimizing Chemotherapy: Concomitant Medication ListsHANIGAN, M. H; DELA CRUZ, B. L; SHORD, S. S et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 114-119, issn 0009-9236, 6 p.Article

Progress and Prospects in Treating Postmenopausal Vaginal AtrophyWINNEKER, R. C; HARRIS, H. A.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 129-132, issn 0009-9236, 4 p.Article

Sexual Side Effects of Pharmacological Treatment of Psychiatric DiseasesSERRETTI, A; CHIESA, A.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 142-147, issn 0009-9236, 6 p.Article

Displacement effects in large-scale chromatography ?JUNGBAUER, A; UHL, K; SCHULZ, P et al.Biotechnology and bioengineering. 1992, Vol 39, Num 5, pp 579-587, issn 0006-3592Article

Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison StudiesANGIOLILLO, D. J; GIBSON, C. M; CHENG, S et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 65-74, issn 0009-9236, 10 p.Article

Dapoxetine for Premature EjaculationFEIGE, A. M; PINSKY, M. R; HELLSTROM, Wjg et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 125-128, issn 0009-9236, 4 p.Article

Developing Treatments for Female Sexual DysfunctionJORDAN, R; HALLAM, T. J; MOLINOFF, P et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 137-141, issn 0009-9236, 5 p.Article

Effects of Plasmodium berghei infection on cytochromes P-450 2E1 and 3A2UHL, K; GRACE, J. M; KOCISKO, D. A et al.European journal of drug metabolism and pharmacokinetics. 1999, Vol 24, Num 2, pp 169-176, issn 0378-7966Article

Characterization of the isoforms of phospholipase A₂ from honeybee venomALTMANN, F; KUBELKA, V; STAUDACHER, E et al.Insect biochemistry. 1991, Vol 21, Num 5, pp 467-472, issn 0020-1790Article

Isolation of isoproteins from monoclonal antibodies and recombinant proteins by chromatofocusingJUNGBAUER, A; TAUER, C; WENISCH, E et al.Journal of chromatography. 1990, Vol 512, pp 157-163, issn 0021-9673, 7 p.Conference Paper

Estrogen Receptors: Therapies Targeted to Receptor SubtypesNILSSON, S; GUSTAFSSON, J-A.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 44-55, issn 0009-9236, 12 p.Article

A Concise Display of Multiple End Points for Benefit-Risk AssessmentLEVITAN, B.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 56-59, issn 0009-9236, 4 p.Article

Comparison of QTc Data Analysis Methods Recommended by the ICH E14Guidance and Exposure-Response Analysis: Case Study of a Thorough QT Study of AsenapineCHAPEL, S; HUTMACHER, M. M; BOCKBRADER, H et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 75-80, issn 0009-9236, 6 p.Article

Use of Serotonergic Drugs and the Risk of BleedingVERDEL, B. M; SOUVEREIN, P. C; MEENKS, S. D et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 89-96, issn 0009-9236, 8 p.Article

Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed PharmacoqenomicsJI, Y; HEBBRING, S; MRAZEK, D. A et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 97-104, issn 0009-9236, 8 p.Article

Pharmacologic Development of Male Hormonal Contraceptive AgentsROTH, M. Y; AMORY, J. K.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 133-136, issn 0009-9236, 4 p.Article

A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetranceMOOLMAN, J. A; REITH, S; VOSBERG, H.-P et al.Circulation (New York, N.Y.). 2000, Vol 101, Num 12, pp 1396-1402, issn 0009-7322Article

Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins : Tolerance of a new recombinant hirudinKOCH, P; MÜNSSINGER, T; RUPP-JOHN, C et al.Journal of the American Academy of Dermatology. 2000, Vol 42, Num 4, pp 612-619, issn 0190-9622Article

A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genesJESCHKE, B; UHL, K; WEIST, B et al.Human genetics. 1998, Vol 102, Num 3, pp 299-304, issn 0340-6717Article

Scaleup of monoclonal antibody purification using radial streaming ion exchange chromatographyJUNGBAUER, A; UNTERLUGGAUER, F; UHL, K et al.Biotechnology and bioengineering. 1988, Vol 32, Num 3, pp 326-333, issn 0006-3592Article